Back
BeiGene 10K Form
Sell
22
BGNE
BeiGene
Last Price:
186.88
Seasonality Move:
11.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BGNE News And Ratings
See the #1 stock for the next 7 days that we like better than BGNE
BGNE Financial Statistics
Sales & Book Value
| Annual Sales: | $1.42B |
|---|---|
| Cash Flow: | $-260.45M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $36.16 |
| Price / Book: | 5.09 |
Profitability
| EPS (TTM): | -9.36000 |
|---|---|
| Net Income (TTM): | $-959.49M |
| Gross Margin: | $1.13B |
| Return on Equity: | -23.11% |
| Return on Assets: | -15.83% |
BeiGene Earnings Forecast
Key BeiGene Financial Ratios
- The Gross Profit Margin over the past 10 years for BGNE is 79.77%.
- The Selling, General & Administrative Expenses for BGNE have been equal to 90.25% of Gross Profit Margin.
- The Research & Development expenses have been 115.86% of Revenue.
- The Interest Expense is -42.19% of Operating Income.
- The Net Earning history of BGNE is -141.52% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 2 years.
BeiGene Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | BGNE |
| CUSIP: | 07725L |
| Website: | beigene.com |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 3.16 |
| Quick Ratio: | 2.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |